Louis Szeponik

7PUBLICATIONS
28CO-AUTHORS
Gene and molecular therapySolid tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 02, 2026
Assessing Cell-Specific Delivery and Efficacy of Therapeutic Oligonucleotides Using Combined RNAscope Plus and Protein Multiplexing in FFPE Tissue.

|Apr 16, 2025
Breast cancer patient-derived scaffolds enhance the understanding of PD-L1 regulation and T cell cytotoxicity.

Elena Garre, Sara Rhost, Anna Gustafsson

|May 14, 2022
Impact of thymidine phosphorylase and CD163 expression on prognosis in stage II colorectal cancer.

Donia Kaidi, Louis Szeponik, Ulf Yrlid

|Oct 23, 2021
Antigen Presenting Cells from Tumor and Colon of Colorectal Cancer Patients Are Distinct in Activation and Functional Status, but Comparably Responsive to Activated T Cells.

Frank Liang, Azar Rezapour, Louis Szeponik

|Mar 19, 2020
Regulatory T cells specifically suppress conventional CD8αβ T cells in intestinal tumors of APCMin/+ mice.

Louis Szeponik, Paulina Akeus, William Rodin

|Jan 23, 2019
Interleukin 4 induces rapid mucin transport, increases mucus thickness and quality and decreases colitis and Citrobacter rodentium in contact with epithelial cells.

S Sharba, N Navabi, M Padra

Pageof 2

Frequent Collaborators

3 joint publications

Ulf Yrlid

1 joint publications

S Sharba

1 joint publications

N Navabi

1 joint publications

J K Gustafsson